<div id="readability-page-1"><p>Cullen Investment Group LTD. raised its position in  CME Group Inc. (NASDAQ:CME - Free Report) by 29.8% during the third quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 38,919 shares of the financial services provider's stock after purchasing an additional 8,942 shares during the quarter. CME Group accounts for approximately  1.4% of Cullen Investment Group LTD.'s portfolio, making the stock its 20th largest position. Cullen Investment Group LTD.'s holdings in CME Group were worth $10,301,000 at the end of the most recent reporting period.</p><ul><li>Capitalize on Volatility: 3 Finance Stocks Thriving in 2025</li></ul><p>A number of other large investors also recently added to or reduced their stakes in the company. Webster Bank N. A. raised its holdings in shares of  CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after buying an additional 60 shares during the period.  Highline Wealth Partners LLC boosted its holdings in  CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 43 shares during the period.  Sagard Holdings Management Inc. acquired a new position in  CME Group in the 2nd quarter valued at about $30,000.  Ransom Advisory Ltd purchased a new stake in  CME Group during the first quarter worth about $31,000.  Finally, Trifecta Capital Advisors LLC lifted its position in shares of  CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider's stock worth $31,000 after purchasing an additional 42 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds. </p><h2>CME Group Price Performance</h2><p>CME Group stock opened at $272.95 on Wednesday. The stock has a market cap of $98.43 billion, a P/E ratio of 26.45, a price-to-earnings-growth ratio of 4.06 and a beta of 0.28. The company has a fifty day simple moving average of $272.24 and a 200-day simple moving average of $272.02. CME Group Inc. has a 12-month low of $224.62 and a 12-month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. </p><ul><li>Morgan Stanley: 3 Financial Stocks That Will Thrive in Volatility</li></ul><p>CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the prior year, the company posted $2.68 earnings per share. CME Group's revenue for the quarter was down 3.0% compared to the same quarter last year.  Equities analysts expect that  CME Group Inc. will post 10.49 EPS for the current fiscal year. </p><h2>CME Group Dividend Announcement</h2><p>The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group's dividend payout ratio (DPR) is 48.45%. </p><h2>Insiders Place Their Bets</h2><ul><li>4 Stocks Planning to Return Capital With Hefty Buyback Programs</li></ul><p>In other CME Group news, Director William R. Shepard bought 262 shares of the firm's stock in a transaction that occurred on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the purchase, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 26,392 shares of company stock worth $7,104,984 in the last three months. 0.30% of the stock is owned by company insiders. </p><h2>Wall Street Analysts Forecast Growth</h2><p>CME has been the subject of a number of research reports. Barclays lifted their price objective on shares of CME Group from $280.00 to $304.00 and gave the company an &#34;equal weight&#34; rating in a report on Friday. Jefferies Financial Group decreased their price target on shares of CME Group from $313.00 to $304.00 and set a &#34;buy&#34; rating for the company in a research report on Friday, October 10th. Keefe, Bruyette &amp; Woods boosted their price target on shares of CME Group from $283.00 to $287.00 and gave the stock a &#34;market perform&#34; rating in a research note on Monday, October 13th. Weiss Ratings  reiterated a &#34;buy (b)&#34; rating on shares of CME Group in a research note on Wednesday, October 8th. Finally, Piper Sandler boosted their target price on CME Group from $296.00 to $313.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, November 13th. Eight analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned  a Sell rating to the stock. According to MarketBeat.com, the company  has an average rating of &#34;Hold&#34; and an average target price of $290.00.</p><p><b>View Our Latest Research Report on CME</b></p><h2>About CME Group</h2> (Free Report)<p>CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.</p><h2>See Also</h2><ul><li>Five stocks we like better than CME Group</li><li>What is the S&amp;P/TSX Index?</li><li>Why Taiwan Semiconductor's 6.5% Dip Could Be a Smart Buy</li><li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li><li>RTX Surges to Record Highs as Defense Orders Explode</li><li>How to Use the MarketBeat Dividend Calculator</li><li>Smart Money Is Buying Auto Suppliers, Not Car Brands</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q01F?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q01F"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in CME Group Right Now?</h2><p>Before you consider CME Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.</p><p>While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Cullen Investment Group LTD. increased its stake in CME Group Inc. by 29.8% in the third quarter, now holding 38,919 shares valued at $10.3 million. This makes CME Group the 20th largest position in Cullen's portfolio. The stock opened at $272.95 with a market cap of $98.43 billion. CME Group announced a quarterly dividend of $1.25 per share, payable on December 30th.</p>

CME Group Inc. $CME Shares Purchased by Cullen Investment Group LTD.